Rahul Aggarwal, MD

Rahul Aggarwal, MD, shares key takeaways from the PRESTO trial as well as remaining questions in the field.

Rahul Aggarwal, MD, highlights final results from the phase 3 PRESTO trial in biochemically relapsed prostate cancer.